Menu
GWAS Study

Exome Array Analysis of 9721 Ischemic Stroke Cases from the SiGN Consortium.

Xu H, Nguyen K, Gaynor BJ et al.

36672803 PubMed ID
GWAS Study Type
145382 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

XH
Xu H
NK
Nguyen K
GB
Gaynor BJ
LH
Ling H
ZW
Zhao W
MP
McArdle PF
OT
O'Connor TD
SO
Stine OC
RK
Ryan KA
LM
Lynch M
SJ
Smith JA
FJ
Faul JD
HY
Hu Y
HJ
Haessler JW
FM
Fornage M
KC
Kooperberg C
OB
On Behalf Of The Trans-Omics For Precision Medicine TOPMed Stroke Working Group None
PJ
Perry JA
HC
Hong CC
CJ
Cole JW
PE
Pugh E
DK
Doheny K
KS
Kardia SLR
WD
Weir DR
KS
Kittner SJ
MB
Mitchell BD
Chapter II

Abstract

Summary of the research findings

Recent genome wide association studies have identified 89 common genetic variants robustly associated with ischemic stroke and primarily located in non-coding regions. To evaluate the contribution of coding variants, which are mostly rare, we performed an exome array analysis on 106,101 SNPs for 9721 ischemic stroke cases from the SiGN Consortium, and 12,345 subjects with no history of stroke from the Health Retirement Study and SiGN consortium. We identified 15 coding variants significantly associated with all ischemic stroke at array-wide threshold (i.e., p < 4.7 × 10-7), including two common SNPs in ABO that have previously been associated with stroke. Twelve of the remaining 13 variants were extremely rare in European Caucasians (MAF < 0.1%) and the associations were driven by African American samples. There was no evidence for replication of these associations in either TOPMed Stroke samples (n = 5613 cases) or UK Biobank (n = 5874 stroke cases), although power to replicate was very low given the low allele frequencies of the associated variants and a shortage of samples from diverse ancestries. Our study highlights the need for acquiring large, well-powered diverse cohorts to study rare variants, and the technical challenges using array-based genotyping technologies for rare variant genotyping.

7,921 European ancestry cases, 9,911 European ancestry controls, 1,044 African American cases, 1,353 African American controls, 756 cases, 1,081 controls

Chapter III

Study Statistics

Key metrics and study information

145382
Total Participants
GWAS
Study Type
Yes
Replicated
5,874 European ancestry cases, 117,442 European ancestry controls
Replication Participants
European, African American or Afro-Caribbean
Ancestry
Austria, Sweden, U.S., Belgium, Poland, U.K., Spain
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.